The BNIKF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BNIKF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The BNIKF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View BNIKF Detailed Price Forecast - CNN Money||View BNIKF Detailed Summary - Google Finance|
|View BNIKF Detailed Summary - Yahoo! Finance||View BNIKF Stock Research & Analysis - Zacks.com|
|View BNIKF Trends & Analysis - Trade-Ideas||View BNIKF Major Holders - Barrons|
|View BNIKF Call Transcripts - NASDAQ||View BNIKF Breaking News & Analysis - Seeking Alpha|
|View BNIKF Annual Report - CompanySpotlight.com||View BNIKF OTC Short Report - OTCShortReport.com|
|View BNIKF Fundamentals - TradeKing||View BNIKF SEC Filings - Bar Chart|
|View Historical Prices for BNIKF - The WSJ||View Performance/Total Return for BNIKF - Morningstar|
|View the Analyst Estimates for BNIKF - MarketWatch||View the Earnings History for BNIKF - CNBC|
|View the BNIKF Earnings - StockMarketWatch||View BNIKF Buy or Sell Recommendations - MacroAxis|
|View the BNIKF Bullish Patterns - American Bulls||View BNIKF Short Pain Metrics - ShortPainBot.com|
|View BNIKF Stock Mentions - StockTwits||View BNIKF Stock Mentions - PennyStockTweets|
|View BNIKF Stock Mentions - Twitter||View BNIKF Investment Forum News - Investor Hub|
|View BNIKF Stock Mentions - Yahoo! Message Board||View BNIKF Stock Mentions - Seeking Alpha|
|View Insider Transactions for BNIKF - SECform4.com||View Insider Transactions for BNIKF - Insider Cow|
|View BNIKF Major Holdings Summary - CNBC||View Insider Disclosure for BNIKF - OTC Markets|
|View Insider Transactions for BNIKF - Yahoo! Finance||View Institutional Holdings for BNIKF - NASDAQ|
|View BNIKF Stock Insight & Charts - FinViz.com||View BNIKF Investment Charts - StockCharts.com|
|View BNIKF Stock Overview & Charts - BarChart||View BNIKF User Generated Charts - Trading View|
Posted on Tuesday April 24, 2018
NASDAQ: BNTCW) today provided an update on its two lead programs in head and neck squamous cell carcinoma (HNSCC) and oculopharyngeal muscular dystrophy (OPMD). This update should be read in conjunction with the latest corporate presentation which can be found on the Company's website. The first clinical site has now been opened in Australia and the Company anticipates having additional Australian sites open later this month. Regulatory review with the Ministry of Health is ongoing in Russia and the Company expects approval at the end of May.
Benitec Biopharma Launches its Phase 2 Oncology Study in Australia
Posted on Monday March 05, 2018
NASDAQ: BNTCW) ("Benitec" or "the Company"), a biotechnology company developing innovative therapeutics based on a combination of gene therapy and its patented gene-silencing technology named ddRNAi or 'expressed RNAi', today announced the start of its Phase 2 clinical study in Australia with BB-401 as a treatment for patients with head and neck squamous cell carcinoma (HNSCC). The Phase 2 open label study has been designed to explore the safety, tolerability and efficacy of BB-401 following intratumoral injections into the lesions of patients with recurrent or metastatic HNSCC. The study will enrol up to 30 patients at 5-8 sites across Australia and Russia. The trial is registered on www.clinicaltrials.gov with the identifier: NCT03433027, where more details can be found.
Benitec Biopharma reports financial results for the 2018 fiscal second quarter and provides operational update
Posted on Thursday February 22, 2018
SYDNEY , Feb. 22, 2018 /PRNewswire/ -- Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) ("Benitec" or "the Company"), a biotechnology company developing innovative ...
Federal R&D Tax Credit Received
Posted on Tuesday January 23, 2018
SYDNEY , Jan. 23, 2018 /PRNewswire/ -- Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) advises that it has received a $4,112,058 cash refund for the year ended 2017 under the Federal ...